Barclays’s EnteroMedics ETRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-40
Closed – – 7412
2017
Q3
$0 Buy
+40
New – ﹤0.01% 7372
2017
Q2
– Sell
-401
Closed -$2K – 7318
2017
Q1
$2K Buy
+401
New +$2.96K ﹤0.01% 6539
2013
Q3
– Sell
-89
Closed -$106K – 8003
2013
Q2
$106K Hold
89
– – ﹤0.01% 5751

Other funds holding ETRM

Barclays's ETRM Position: Q4 2017 in Review

Barclays sold out of EnteroMedics (ETRM) in Q4 2017, closing a stake of 40 shares.

Barclays first reported a position in ETRM in Q2 2013 and held it in 3 quarters. The position peaked at $106K in Q2 2013. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.

  • Barclays reported no remaining EnteroMedics position as of Q4 2017 after selling out during the quarter.
  • Barclays sold 40 EnteroMedics shares in Q4 2017.
  • Barclays first reported a position in EnteroMedics in Q2 2013 and held it in 3 quarters.
  • Barclays's EnteroMedics position peaked at $106K in Q2 2013.
  • 1 fund tracked by Wall St. Rank held EnteroMedics as of Q4 2017.

Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.